Drug Repurposing for Unmet Medical Needs; Request for Information

NonrulemakingNoticeFDA-2026-N-4492-0001
🔔 Subscribe
Comments
323
Awaiting comments
Deadline
Closed on Jun 12, 2026
Closed Jun 12, 2026
Net support
+94%
Support minus oppose · campaigns included
+94% excluding campaigns
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
May 12, 2026
Comment period
May 12, 2026 – Jun 12, 2026
Agency
Food and Drug Administration (FDA)
FR Doc
2026-09366
Analysis

Overview

What the public is saying — stance, who's commenting, and the issues they raise.

Analyzed 309 of 323 comments
96%· analysis in progress

Stance breakdown

+94%
Net support
Support290Oppose1Other18
Showing organic comments only. With campaigns included, net support is +94%.

Who commented

Breakdown by commenter type, organic comments only.

Academic
7
Advocacy
23
Business
16
Individual
262
Other
1

Comments over time

Weekly arrivals, stacked by stance, organic only.

Posted May 12, 2026Deadline Jun 12, 2026
Support290Oppose1Other18

Support × commenter type

How each type splits across stance.

A paid feature

The stance-by-type cross-tab is part of the paid plan.

Start free trial

Issues raised

The docket's canonical issues. Select one to filter the Explorer.

Issues are identified as comment analysis progresses — nothing tagged on this document yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Read all 323 comments

The Explorer — every comment with stance, commenter type, and AI summaries — is part of the paid plan. $180/month per seat, 30-day money-back guarantee.

© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets